Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) has 229 institutional investors that have filed 13F reports for the period ending March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 5,754,957 | 519,528 | 9.92% | $194,690,195.00 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 31 Mar, 2026 | 5,684,000 | 524,495 | 10.17% | $192,289,720.00 |
| State Street Corp | 31 Mar, 2026 | 3,364,879 | 256,734 | 8.26% | $113,719,376.00 |
| ARMISTICE CAPITAL, LLC | 31 Mar, 2026 | 2,716,000 | -320,000 | -10.54% | $91,882,280.00 |
| Erste Asset Management GmbH | 31 Mar, 2026 | 2,704,900 | -100,000 | -3.57% | $80,092,089.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 2,681,169 | 843,983 | 45.94% | $90,703,947.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 2,632,316 | 2,632,316 | 0.00% | $89,051,250.00 |
| Lynx1 Capital Management LP | 31 Mar, 2026 | 2,611,568 | 2,531,944 | 3,179.88% | $88,349,345.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 2,611,035 | 2,611,035 | 0.00% | $88,331,314.00 |
| BNP Paribas Asset Management Holding S.A. | 31 Mar, 2026 | 1,580,840 | 220,110 | 16.18% | $53,479,817.00 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 31 Mar, 2026 | 1,494,435 | -206,974 | -12.16% | $50,557,000.00 |
| T. Rowe Price Investment Management, Inc. | 31 Mar, 2026 | 1,488,740 | 1,486,956 | 83,349.56% | $50,365.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 1,467,910 | 54,372 | 3.85% | $49,670,160.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Mar, 2026 | 1,344,953 | 202,521 | 17.73% | $45,499,760.00 |
| MPM BioImpact LLC | 31 Mar, 2026 | 1,306,261 | 2,888 | 0.22% | $44,190,810.00 |
| Frazier Life Sciences Management, L.P. | 31 Mar, 2026 | 1,256,080 | -23,674 | -1.85% | $42,493,186.00 |
| GW&K Investment Management, LLC | 31 Mar, 2026 | 1,214,901 | 7,600 | 0.63% | $41,101.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 1,151,614 | 147,273 | 14.66% | $38,940,060.00 |
| Morgan Stanley | 31 Mar, 2026 | 967,525 | 73,488 | 8.22% | $32,731,410.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 805,776 | -1,262,172 | -61.03% | $27,259,402.00 |